The mechanisms of resistance to chemotherapeutics share many features, such as alterations in the drug target,37 activation of the prosurvival pathways, proliferation, and activation of MDR protein as well as tumor initiating cells.38 Studies in multiple types of cancers have implicated the role of NEK2 in drug resistance. This evidence concerns the gene NEK2 and neoplasm.